Fluoxetine for anxiety

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Fluoxetine for Anxiety: Efficacy and Safety

Introduction to Fluoxetine for Anxiety Disorders

Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is widely used for treating various anxiety disorders. Its mechanism involves enhancing serotonergic neurotransmission, which is believed to alleviate anxiety symptoms . This article synthesizes research findings on the efficacy and safety of fluoxetine in treating anxiety, particularly in children and adolescents.

Efficacy of Fluoxetine in Childhood Anxiety Disorders

Acute Treatment Efficacy

Several studies have demonstrated the effectiveness of fluoxetine in reducing anxiety symptoms in children and adolescents. In a randomized controlled trial (RCT), fluoxetine significantly reduced anxiety symptoms and improved functioning in youths aged 7-17 with generalized anxiety disorder, separation anxiety disorder, and social phobia. Approximately 61% of patients on fluoxetine showed much to very much improvement compared to 35% on placebo . Another open-label study reported that 81% of patients with various anxiety disorders showed moderate to marked improvement in anxiety symptoms after fluoxetine treatment .

Long-Term Treatment Efficacy

Long-term studies also support the efficacy of fluoxetine. In a one-year follow-up study, children and adolescents who continued fluoxetine treatment showed significantly better outcomes in anxiety symptoms compared to those who did not take any medication . This suggests that fluoxetine is effective for the maintenance treatment of anxiety disorders in this population.

Comparative Efficacy with Other Treatments

Fluoxetine has been compared with other SSRIs and tricyclic antidepressants (TCAs) in treating anxiety disorders. It was found to be as effective as citalopram, desipramine, imipramine, and moclobemide in treating panic disorder, and similar in efficacy to sertraline and paroxetine in treating major depression with high levels of anxiety Hurst2000Fava2000. However, some studies indicated that fluoxetine might have lower response rates compared to clomipramine in treating obsessive-compulsive disorder .

Safety and Tolerability

Side Effects

Fluoxetine is generally well tolerated. Common side effects include mild and transient headaches, gastrointestinal issues, drowsiness, sleep problems, decreased appetite, nausea, and abdominal pain Birmaher2003Fairbanks1997. In comparison to other SSRIs, fluoxetine is associated with fewer adverse effects and withdrawal reactions .

Long-Term Safety

Long-term safety data indicate that fluoxetine is well tolerated over extended periods. In a study assessing continuation treatment in major depressive disorder with associated anxiety, fluoxetine did not show significant differences in time to relapse between high and low anxiety subgroups, suggesting its safety and efficacy in long-term use .

Conclusion

Fluoxetine is an effective and well-tolerated treatment for various anxiety disorders in children, adolescents, and adults. It shows significant efficacy in both acute and long-term treatment phases, with a favorable safety profile compared to other SSRIs and TCAs. Further research is needed to optimize treatment strategies and determine the long-term risks and benefits of fluoxetine for anxiety disorders.

Sources and full results

Most relevant research papers on this topic

Fluoxetine for the treatment of childhood anxiety disorders.

Fluoxetine is effective and well-tolerated for acute treatment of anxious youths with generalized anxiety disorder, separation anxiety disorder, and/or social phobia.

RCT

2003·

343citations

·B. Birmaher et al.

Journal of the American Academy of Child and Adolescent Psychiatry·

DOI

Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial.

Fluoxetine is clinically effective for the maintenance treatment of anxiety disorders in children and adolescents, but more randomized, controlled trials are needed to determine long-term risks and benefits.

RCT

2005·

61citations

·D. B. Clark et al.

Journal of the American Academy of Child and Adolescent Psychiatry·

DOI

Fluoxetine for childhood anxiety disorders.

Fluoxetine may be an effective and safe treatment for nondepressed children and adolescents with anxiety disorders other than OCD and panic disorder.

1994·

135citations

·B. Birmaher et al.

Journal of the American Academy of Child and Adolescent Psychiatry·

DOI

Fluoxetine : A review of its use in anxiety disorders and mixed anxiety and depression

Fluoxetine is effective in short-term treatment of panic, social anxiety, post-traumatic stress, and obsessive-compulsive disorders, with potential for long-term improvement.

Literature Review

2000·

36citations

·M. Hurst et al.

CNS Drugs·

DOI

Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.

High anxiety does not impact the benefit of continuation therapy with fluoxetine for major depressive disorder, but it predicts increased risk of relapse in individuals not maintaining antidepressant therapy for the duration of treatment.

RCT

2004·

13citations

·M. Joliat et al.

The Journal of clinical psychiatry·

DOI

Open Fluoxetine Treatment of Mixed Anxiety Disorders in Children and Adolescents

Fluoxetine treatment effectively improves separation anxiety disorder and social phobia in children and adolescents with mixed anxiety disorders, with lower doses needed for those with only one anxiety disorder.

1997·

110citations

·JANET M. Fairbanks et al.

Journal of Child and Adolescent Psychopharmacology·

DOI

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

Anxiety in major depression does not affect response to antidepressants, so antidepressant selection should be based on an agent's overall risk:benefit ratio, not the presence or absence of anxiety.

Meta-Analysis

1994·

140citations

·G. Tollefson et al.

The Journal of clinical psychiatry

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fluoxetine, sertraline, and paroxetine are equally effective and well-tolerated in treating major depression in patients with high anxiety symptoms.

RCT

2000·

123citations

·M. Fava et al.

Journal of affective disorders·

DOI

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression.

Low-dose cotherapy of fluoxetine with clonazepam is safe and accelerates depression treatment, reducing anxiety, sleep disturbance, and core symptoms of low mood and loss of interest.

RCT

2000·

88citations

·P. Londborg et al.

Journal of affective disorders·

DOI

Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression

Maternal fluoxetine treatment during pregnancy increases anxiety and depressive-like behaviors in offspring, potentially through alterations in the glutamatergic system.

Very Rigorous Journal

2019·

34citations

·Samuel J. Millard et al.

Journal of Psychopharmacology·

DOI

Try another search

can marijuana cause schizophrenia

testing for test anxiety

opioid treatment

what is thyroxine

magnesium and depression

how long cocaine stays in system